CEP
DGX icon

Chicago Equity Partners’s Quest Diagnostics DGX Stock Holding History

Chicago Equity Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,355
Closed -$221K – 754
2017
Q3 		$221K Sell
2,355
-980
-29% -$104K 0.01% 719
2017
Q2 		$371K Buy
3,335
+635
+24% +$67.1K 0.01% 673
2017
Q1 		$265K Buy
2,700
+230
+9% +$21.9K 0.01% 678
2016
Q4 		$227K Buy
+2,470
New +$213K 0.01% 686
2014
Q2 		– Sell
-3,900
Closed -$225K – 460
2014
Q1 		$225K Buy
+3,900
New +$209K 0.01% 420

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Chicago Equity Partners's DGX Position: Q4 2017 in Review

Chicago Equity Partners sold out of Quest Diagnostics (DGX) in Q4 2017, closing a stake of 2,355 shares — an estimated $221K sold.

Chicago Equity Partners first reported a position in DGX in Q1 2014 and held it in 5 quarters. The position peaked at $371K in Q2 2017. 631 funds tracked by Wall St. Rank hold DGX as of Q4 2017.

  • Chicago Equity Partners reported no remaining Quest Diagnostics position as of Q4 2017 after selling out during the quarter.
  • Chicago Equity Partners sold 2,355 Quest Diagnostics shares in Q4 2017, an estimated $221K.
  • Chicago Equity Partners first reported a position in Quest Diagnostics in Q1 2014 and held it in 5 quarters.
  • Chicago Equity Partners's Quest Diagnostics position peaked at $371K in Q2 2017.
  • 631 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2017.

Based on Chicago Equity Partners's 13F filing for Q4 2017, filed 31 Jan 2018.